3M Reports Record Fourth-Quarter and Calendar Year Sales and Earnings

3M (NYSE:MMM) today announced its sales and profit results for the fourth-quarter and calendar year 2006.

For the 2006 calendar year, net income was $3.9 billion, or $5.06 per share, versus $3.1 billion, or $3.98 per share, an increase of 24 percent and 27 percent, respectively. Full-year 2006 net income includes a net profit of $438 million, or $0.57 per share, largely due to a gain on the sale of those geographic regions of the company's global branded pharmaceuticals business that closed in December, net of various other special items(a-h). Full-year 2005 net income includes net costs due to special items(i-j) of $110 million, or $0.14 per share. Included in these full-year results are stock option expenses of $0.17 per share in 2006 and $0.14 per share in 2005(p).

Calendar year 2006 sales totaled $22.9 billion, an 8.3 percent increase over 2005. Local-currency sales increased 7.7 percent, including 2.1 percent from acquisitions. Selling prices declined 0.5 percent on average, and currency impacts added 0.6 percent to 2006 full-year sales growth. Calendar-year local-currency sales growth was driven by increases of 13.2 percent in Safety, Security and Protection Services, 9.1 percent in Industrial and Transportation, 6.9 percent in Display and Graphics, 6.1 percent in Consumer and Office, 6 percent in Health Care and 5.6 percent in Electro and Communications. All six businesses posted positive local-currency sales growth for the third consecutive year.

“This was a good year for 3M, as we generated record sales and profits,” said George W. Buckley, 3M chairman, president and CEO. “We accelerated investments in many areas, including research and development, sales and marketing, growth-oriented capital investments and selected acquisitions, while maintaining our outstanding profitability levels. These investments have strengthened our positions in growing markets, and as they begin to bear fruit, I am confident that we will transform 3M into a faster-growing, higher-performing enterprise. I would like to personally thank 3M employees worldwide for their many contributions in 2006.”

Fourth-quarter net income was $1.2 billion, or $1.57 per share, versus $746 million, or $0.97 per share, in the fourth quarter of 2005. Net income and earnings per share increased 58 percent and 62 percent, respectively. Fourth-quarter 2006 net income includes a net profit of $354 million, or $0.47 per share, again largely due to a gain on the sale of those geographic regions of the company's global branded pharmaceuticals business that closed in December, net of various other special items(a-h). Fourth-quarter 2005 net income includes an expense of $35 million, or $0.04 per share, due to the effect of FIN 47(j). Included in these results are stock option expenses of $0.04 per share in the fourth quarter of 2006 and $0.02 per share in the fourth quarter of 2005(p).

Fourth-quarter worldwide sales were $5.8 billion, up 8.6 percent compared to the fourth quarter of 2005. Total local-currency sales increased 5.8 percent, led by a 12.2 percent increase in Safety, Security and Protection Services and an 8.9 percent improvement in Health Care. Local-currency sales increased 5.6 percent in Consumer and Office, 4.8 percent in Industrial and Transportation, 3.6 percent in Display and Graphics and 2.6 percent in Electro and Communications. Total-company local-currency sales growth includes 1.9 points from acquired businesses. Currency impacts added 2.8 percent to fourth-quarter growth, and selling prices declined 1 percent versus last year’s comparable quarter.

Fourth-quarter local-currency growth was 10.5 percent in Europe, 10.2 percent in Latin America and 5 percent in Asia Pacific. In the United States, sales grew 3.3 percent despite a significant slowdown in the housing industry, which hurt growth by an estimated 3 percentage points.

“Looking ahead, despite what appears to be slightly moderating economic growth worldwide, I am very optimistic about the future of our company,” said Buckley. “We will continue to drive our growth agenda, which will be funded via aggressive productivity improvement efforts, such as global strategic sourcing and lean six sigma.”

3M also provided its outlook for 2007 sales and earnings. The company expects 2007 per share earnings to be in the range of $5.20 to $5.45, which includes a net gain, after costs for known restructuring actions, of approximately $0.60 to $0.70 per diluted share due to the sale in the first quarter of the company’s branded pharmaceuticals business in Europe. Also included in this range is an estimated $0.21 per share due to expensing of stock options. 3M also expects full-year local-currency sales growth, adjusted for the divestiture of its global branded pharmaceuticals business, to be between 6 and 10 percent, which includes approximately 1.5 percentage points due to acquisitions closed as of this date. Including the global branded pharmaceuticals sales in 2006, total local-currency sales growth for 2007 is expected to be between 2 and 6 percent.

George W. Buckley, and Patrick D. Campbell, senior vice president and chief financial officer, will conduct an investor teleconference at 9 a.m. Eastern Time (8 a.m. Central Time) today. Investors can access a webcast of this conference, along with related charts and materials, at http://investor.3M.com.

Forward-Looking Statements

This news release contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) about the company’s financial results and estimates, business prospects, and products under development that involve substantial risks and uncertainties. You can identify these statements by the use of words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will,” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic conditions; (2) competitive conditions and customer preferences; (3) foreign currency exchange rates and fluctuations in those rates; (4) the timing and acceptance of new product offerings; (5) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (6) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (7) generating less productivity improvements than estimated; and (8) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the company’s Annual Report on Form 10-K for the year ended Dec. 31, 2005 and the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2006, June 30, 2006 and Sept. 30, 2006 (the “Reports”). Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under Part I, Item 1A (Annual Report) and Part II, Item 1A (Quarterly Report), “Risk Factors.” The information contained in this news release is as of the date indicated. The company assumes no obligation to update any forward-looking statements contained in this news release as a result of new information or future events or developments.

About 3M - A Global, Diversified Technology Company

Every day, 3M people find new ways to make amazing things happen. Wherever they are, whatever they do, the company’s customers know they can rely on 3M to help make their lives better. 3M's brands include Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti. Serving customers in more than 200 countries around the world, the people of 3M use their expertise, technologies and global strength to lead in major markets including consumer and office; display and graphics; electronics and telecommunications; safety, security and protection services; health care; industrial and transportation. For more information, including the latest product and technology news, visit www.3M.com.

Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti are trademarks of 3M.

3M Company and Subsidiaries

CONSOLIDATED STATEMENT OF INCOME

(Millions, except per-share amounts)
(Unaudited)
                 
    Three-months ended   Twelve-months ended
    Dec. 31   Dec. 31
    2006   2005   2006   2005
Net sales   $5,782     $5,325     $22,923     $21,167  
Operating expenses                
Cost of sales   3,162     2,622     11,713     10,408  
Selling, general and administrative expenses   1,375     1,191     5,066     4,631  
Research, development and related expenses   509     322     1,522     1,274  
Gain on sale of pharmaceuticals business (a)   (1,074 )   -     (1,074 )   -  
Total   3,972     4,135     17,227     16,313  
Operating income   1,810     1,190     5,696     4,854  
Interest expense and income                
Interest expense   38     23     122     82  
Interest income   (16 )   (11 )   (51 )   (56 )
Total   22     12     71     26  
Income before income taxes, minority interest and cumulative effect of accounting change   1,788     1,178     5,625     4,828  
Provision for income taxes   596     382     1,723     1,627  
Minority interest   16     15     51     55  
Income before cumulative effect of accounting change   1,176     781     3,851     3,146  
Cumulative effect of accounting change (j)   -     (35 )   -     (35 )
Net income   $1,176     $746     $3,851     $3,111  
Weighted average common shares outstanding - basic   735.4     757.6     747.5     764.9  
Earnings per share - basic (p)                
Income before cumulative effect of accounting change   $1.60     $1.03     $5.15     $4.11  
Cumulative effect of accounting change (j)   -     (0.05 )   -     (0.04 )
Net Income   $1.60     $0.98     $5.15     $4.07  
Weighted average common shares outstanding - diluted   748.6     771.5     761.0     781.3  
Earnings per share - diluted (p)                
Income before cumulative effect of accounting change   $1.57     $1.01     $5.06     $4.03  
Cumulative effect of accounting change (j)   -     (0.04 )   -     (0.05 )
Net income   $1.57  

 

$0.97     $5.06     $3.98  
Cash dividends paid per common share                
  $0.46     $0.42     $1.84     $1.68  
                         
 

3M Company and Subsidiaries

SUPPLEMENTAL CONSOLIDATED STATEMENT OF INCOME INFORMATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(Millions, except per-share amounts)
(Unaudited)
         
In addition to reporting financial results in accordance with U.S. generally accepted accounting principles (GAAP), the company also discusses non-GAAP measures that exclude special items. Operating income, net income, and diluted earnings per share measures that exclude special items are not in accordance with, nor are they a substitute for, GAAP measures. Special items represent significant charges or credits that are important to an understanding of the company’s ongoing operations. The company uses these non-GAAP measures to evaluate and manage the company’s operations. The company believes that discussion of results excluding special items provides a useful analysis of ongoing operating trends. The determination of special items may not be comparable to similarly titled measures used by other companies.
         
The reconciliation provided below reconciles the non-GAAP financial measures with the most directly comparable GAAP financial measures for the three months and twelve months ended Dec. 31, 2006.
         
    Three-months ended   Twelve-months ended
    Dec. 31, 2006   Dec. 31, 2006
            Diluted           Diluted
            earnings           earnings
    Operating   Net   per   Operating   Net   per
    income   income   share   income   income   share
Reported GAAP measure   $1,810     $1,176     $1.57     $5,696     $3,851     $5.06  
         
Special items:                        
Gain on sale of pharmaceuticals business (a)                        
  (1,074 )   (674 )   (0.90 )   (1,074 )   (674 )   (0.88 )
Restructuring and other actions:                        
Pharmaceuticals business restructuring actions(b):                        
                       
Employee related   77     49     0.06     97     62     0.08  
Asset impairment and other   67     42     0.06     69     44     0.06  
Environmental (c)   13     8     0.01     13     8     0.01  
Overhead reduction actions (d)   112     73     0.10     112     73     0.10  
Businesses-specific restructuring actions (e):                        
                       
Employee related   34     21     0.03     34     21     0.03  
Asset impairment and other   91     57     0.07     91     57     0.07  
Acquired in-process research and development (f)                        
  95     95     0.13     95     95     0.13  
Class action settlement (g)   -     -     -     40     25     0.03  
Benefit from income tax adjustments (h)                        
  -     (25 )   (0.03 )   -     (149 )   (0.20 )
Adjusted Non-GAAP measure   $1,225     $822     $1.10     $5,173     $3,413     $4.49  
 
(a) In December 2006, 3M completed the sale of its global branded pharmaceuticals business in the United States, Canada, and Latin America region and the Asia Pacific region, including Australia and South Africa. 3M received proceeds of $1.209 billion for these transactions and recognized a gain of $1.074 billion. In January 2007, 3M completed the sale of its global branded pharmaceuticals business in Europe, which will be reflected in 3M’s financial statements for the period ending March 31, 2007. In connection with these transactions, 3M’s Drug Delivery Systems Division (DDSD) entered into agreements whereby it became a source of supply to the acquiring companies. The Company expects annual revenues of approximately $100 million from these supply arrangements, with profitability substantially lower than most of our existing Health Care businesses. Because of the extent of the continuing cash flows from these supply agreements in relation to those of the disposed business, the operations of the branded pharmaceuticals business are not classified as discontinued operations.
 
(b) Pharmaceuticals business restructuring actions, primarily in the fourth quarter, included employee related, asset impairment and other costs pertaining to the Company’s exit of its branded pharmaceuticals operations. These costs included severance and benefits for pharmaceuticals business employees who did not retain employment with the buyer, which will reduce cash flows in 2007 when the related severance is paid.
 
(c) In the fourth quarter of 2006, an environmental obligation was recognized in the pharmaceuticals business.
 
(d) In response to the sale of our branded pharmaceuticals business, the Company took actions to reduce worldwide staff overhead in the fourth quarter of 2006. These actions were taken to streamline the company's cost structure and to avoid burdening the company's remaining businesses with the corporate overhead costs that had previously been allocated to the pharmaceuticals division. These costs were recorded in the Health Care segment and will reduce cash flows in 2007 when the related severance is paid.
 
(e) Businesses-specific restructuring actions taken in the fourth quarter of 2006 included employee related costs for severance and benefits, fixed and intangible asset impairments, losses from certain no longer profitable contractual obligations, and expenses from the exit of certain product lines and the streamlining of supply chains in certain businesses.
 
(f) In October 2006, 3M acquired Brontes Technologies Inc., a Lexington, Mass.-based developer of proprietary 3-D imaging technology for dental and orthodontic applications. This transaction resulted in a fourth quarter 2006 charge, reflecting the one time write-off of acquired in-process research and development costs, which is reflected in the “Research, development and related expense” line of the Consolidated Statement of Income.
 
(g) In the second quarter of 2006, 3M recognized an expense after entering into an agreement in principle (which was subsequently executed in the third quarter of 2006) to resolve the antitrust class action involving direct purchasers of branded transparent tape (but not private label tape).
 
(h) In the second, third and fourth quarters of 2006, the company recorded net benefits from income tax adjustments, with $124 million of the $149 million total year adjustment previously described in 3M's Quarterly Report on Form 10-Q for the period ended June 30, 2006 and Sept. 30, 2006.
 

In total, in the fourth quarter of 2006, these special items negatively impacted:

– Cost of sales by $143 million

– Selling, general and administrative expenses by $176 million

– Research, development and related expenses by $170 million

In addition:

– The gain on sale in the fourth quarter of 2006 of $1.074 billion is recorded on a separate line of the Consolidated Statement of Income

– Special items in the second and third quarter of 2006 negatively impacted selling, general and administrative expenses by $62 million.

The reconciliation provided below reconciles the non-GAAP operating income measure by business segment with the most directly comparable GAAP financial measure for the three months and twelve months ended Dec. 31, 2006.

    Three-months ended   Twelve-months ended
    Dec. 31, 2006   Dec. 31, 2006

OPERATING INCOME BY
BUSINESS SEGMENT

 

Reported GAAP
measure

 

Special
items

 

Adjusted Non-
GAAP measure

 

Reported GAAP
measure

 

Special
items

 

Adjusted Non-
GAAP measure

Industrial and Transportation   $301     $15     $316     $1,343     $15     $1,358  
Health Care   999     (695 )   304     1,845     (673 )   1,172  
Display and Graphics   225     39     264     1,062     39     1,101  
Consumer and Office   141     -     141     579     -     579  
Electro and Communications   64     46     110     438     46     484  
Safety, Security and Protection Services   118     10     128     575     10     585  
Corporate and Unallocated   (38 )   -     (38 )   (146 )   40     (106 )
Total Operating Income   $1,810     $(585 )   $1,225     $5,696     $(523 )   $5,173  
                         
 

The reconciliation provided below reconciles the non-GAAP financial measures with the most directly comparable GAAP financial measures for the three months and twelve months ended Dec. 31, 2005.

    Three-months ended   Twelve-months ended
    Dec. 31, 2005   Dec. 31, 2005
                         
                         
            Diluted           Diluted
            Earnings           Earnings
    Operating   Net   per   Operating   Net   per
    income   income   share   income   income   share
                         
Reported GAAP measure   $ 1,190   $ 746   $ 0.97   $ 4,854   $ 3,111   $ 3.98
 
Special items:                        
Jobs Act (i)   -   -   -   -     75     0.09
Cumulative effect of accounting change (j)                        
  -     35     0.04   -     35     0.05
Adjusted Non-GAAP measure   $ 1,190   $ 781   $ 1.01   $ 4,854   $ 3,221   $ 4.12
                                     

(i) In the second quarter of 2005, the Company announced its intent to reinvest $1.7 billion of foreign
earnings in the United States pursuant to the American Jobs Creation Act (Jobs Act) of 2004. As a
consequence, in the second quarter of 2005, 3M recorded a charge of $75 million after-tax.

 

(j) In March 2005, the FASB issued Interpretation No. 47, “Accounting for Conditional Asset Retirement
Obligations – an interpretation of FASB Statement No. 143” (“FIN 47”). In adopting FIN 47 in the fourth
quarter of 2005, 3M recorded a noncash charge of $35 million after-tax, as a cumulative effect of change
in accounting principle. This charge represents conditional retirement obligations associated with 3M’s
long-lived assets.

 
 
3M Company and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEET

(Dollars in millions)
(Unaudited)
         
    Dec. 31,   Dec. 31,
    2006   2005
ASSETS        
Current assets        
Cash and cash equivalents   $1,447   $1,072
Marketable securities - current   471   -
Accounts receivable - net   3,102   2,838
Inventories   2,601   2,162
Other current assets   1,325   1,043
Total current assets   8,946   7,115
Marketable securities - non-current   166   -
Investments   314   272
Property, plant and equipment - net   5,907   5,593
Prepaid pension and postretirement benefits (k)   394   2,905
Goodwill, intangible assets and other assets (k, l)   5,580   4,656
Total assets   $21,307   $20,541
LIABILITIES AND STOCKHOLDERS' EQUITY        
Current liabilities        
Short-term borrowings and current portion of long-term debt   $2,506   $1,072
Accounts payable   1,402   1,256
Accrued payroll   520   469
Accrued income taxes   1,134   989
Other current liabilities   1,761   1,452
Total current liabilities   7,323   5,238
Long-term debt   1,047   1,309
Other liabilities (k)   2,965   3,599
Total liabilities   11,335   10,146
Total stockholders' equity - net (k)   9,972   10,395
Shares outstanding        
Dec. 31, 2006: 734,362,802 shares        
Dec. 31, 2005: 754,538,387 shares        
Total liabilities and stockholders' equity   $21,307   $20,541
         

(k) Reference SFAS No. 158 accounting pronouncements discussion and supplemental Consolidated
Balance Sheet information that follows

         

(l) Approximately $800 million of this increase when compared to year-end 2005 relates to
2006 acquisitions

 
 
3M Company and Subsidiaries

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Dollars in millions)
(Unaudited)
         
    Twelve-months ended
    Dec. 31
    2006   2005
SUMMARY OF CASH FLOW:        
         
NET CASH PROVIDED BY OPERATING ACTIVITIES   $3,839     $4,204  
Cash flows from investing activities:        
Purchases of property, plant and equipment   (1,168 )   (943 )
Acquisitions, net of cash acquired   (888 )   (1,293 )
Proceeds from sale of pharmaceuticals business (a)   1,209     -  
Other investing activities   (613 )   (5 )
NET CASH USED IN        
INVESTING ACTIVITIES   (1,460 )   (2,241 )
Cash flows from financing activities:        
Change in debt   1,135     (485 )
Purchases of treasury stock   (2,351 )   (2,377 )
Reissuances of treasury stock   523     545  
Dividends paid to stockholders   (1,376 )   (1,286 )
Other financing activities   8     (22 )
NET CASH USED IN FINANCING ACTIVITIES   (2,061 )   (3,625 )
Effect of exchange rate changes on cash   57     (23 )
Net increase (decrease) in cash and cash equivalents   375     (1,685 )
Cash and cash equivalents at beginning of period   1,072     2,757  
Cash and cash equivalents at end of period   $1,447     $1,072  
         
 
3M Company and Subsidiaries
SUPPLEMENTAL CASH FLOW AND
OTHER SUPPLEMENTAL FINANCIAL INFORMATION
(Dollars in millions)
(Unaudited)
         
    Twelve-months ended
    Dec. 31
    2006   2005
NON-GAAP MEASURES        
         
Free Cash Flow:        
Net cash provided by operating activities   $3,839     $4,204  
Purchases of property, plant and equipment   (1,168 )   (943 )
Free Cash Flow (m)   $2,671     $3,261  
         
OTHER NON-GAAP MEASURES:        
Net Working Capital Turns (n)   5.4     5.7  
         
Reported (before cumulative effect of

accounting change in 2005):

   
Economic Profit (o)   $2,386     $1,763  
Return on Invested Capital (o)  

25.3%

 

 

22.1%

 

         
Excluding Special Items:        
Economic Profit (o)   $1,948     $1,838  
Return on Invested Capital (o)  

22.5%

 

 

22.6%

 

         

(m) Free cash flow is not defined under U.S. generally accepted accounting
principles (GAAP). Therefore, it should not be considered a substitute for
income or cash flow data prepared in accordance with U.S. GAAP and may
not be comparable to similarly titled measures used by other companies.
The company defines free cash flow as net cash provided by operating activities
less purchases of property, plant and equipment. It should not be inferred that
the entire free cash flow amount is available for discretionary expenditures. The
company believes free cash flow is a useful measure of performance and uses
this measure as an indication of the strength of the company and its ability to
generate cash.

     

(n) The company uses various working capital measures that place emphasis and
focus on certain working capital assets and liabilities. 3M’s net working capital index
is defined as quarterly net sales multiplied by four, divided by ending net accounts
receivable plus inventory less accounts payable. This measure is not recognized
under U.S. generally accepted accounting principles and may not be comparable to
similarly titled measures used by other companies.

     

(o) The company uses non-GAAP measures to focus on shareholder value creation.
3M’s Economic Profit is defined as after-tax operating income less a charge for
operating capital. 3M also uses Return on Invested Capital, defined as after-tax
operating income divided by average operating capital. This measure is presented
as reported and also excluding special items. Special items were previously defined
within the Supplemental Consolidated Statement of Income Information section of this
document. These measures are not recognized under U.S. generally accepted
accounting principles and may not be comparable to similarly titled measures used by
other companies.

 
 
3M Company and Subsidiaries
SALES CHANGE ANALYSIS
(Unaudited)
             
    Three-Months Ended Dec. 31, 2006
             
Sales Change Analysis
By Geographic Area
 

United
States

 

Inter-
national

  Worldwide
Volume - organic   0.8 %   7.3 %   4.9 %
             
Volume - acquisitions, net            
of divestitures   1.8     2.1     1.9  
Volume - total   2.6     9.4     6.8  
             
Price   0.7     (2.0 )   (1.0 )
Total local-currency sales   3.3     7.4     5.8  
             
Translation   -     4.6     2.8  
Total sales change   3.3 %   12.0 %   8.6 %
             

Sales Change Analysis
By International
Geographic Area

 

Local-
currency
Sales

 

Trans-
lation

 

Total
Sales
Change

Europe, Middle East and Africa   10.5 %   8.7 %   19.2 %
             
Asia Pacific   5.0 %   1.9 %   6.9 %
             
Latin America and Canada   9.7 %   1.8 %   11.5 %
             

Worldwide
Sales Change Analysis
By Business Segment

 

Local-
currency
Sales

 

Trans-
lation

 

Total
Sales
Change

Industrial and Transportation   4.8 %   3.2 %   8.0 %
             
Health Care   8.9 %   3.7 %   12.6 %
             
Display and Graphics   3.6 %   1.4 %   5.0 %
             
Consumer and Office   5.6 %   2.1 %   7.7 %
             
Electro and Communications   2.6 %   3.2 %   5.8 %
             
Safety, Security and Protection Services   12.2 %   4.1 %   16.3 %
             

Note: Safety, Security and Protection Services includes a 10.2 percent benefit from acquisitions,
primarily Security Printing and Systems Limited, which was acquired in August 2006.

 
 
3M Company and Subsidiaries

SALES CHANGE ANALYSIS

(Unaudited)
             
    Twelve-Months Ended Dec. 31, 2006
             
Sales Change Analysis
By Geographic Area
  United
States
  Inter-
national
  Worldwide
Volume - organic   3.1 %   8.0 %   6.1 %
             
Volume - acquisitions, net of divestitures   2.6     1.9     2.1  
Volume - total   5.7     9.9     8.2  
             
Price   1.4     (1.8 )   (0.5 )
Total local-currency sales   7.1     8.1     7.7  
             
Translation   -     1.0     0.6  
Total sales change   7.1 %   9.1 %   8.3 %
             
             
Sales Change Analysis
By International
Geographic Area
  Local-
currency
Sales
  Trans-
lation
  Total
Sales
Change
Europe, Middle East and Africa   8.3 %   1.4 %   9.7 %
             
Asia Pacific   9.2 %   (0.4 )%   8.8 %
             
Latin America and Canada   6.1 %   4.4 %   10.5 %
             
             
             
Worldwide
Sales Change Analysis
By Business Segment
  Local-
currency
Sales
  Trans-
lation
  Total
Sales
Change
Industrial and Transportation   9.1 %   0.8 %   9.9 %
             
Health Care   6.0 %   0.7 %   6.7 %
             
Display and Graphics   6.9 %   0.3 %   7.2 %
             
Consumer and Office   6.1 %   0.7 %   6.8 %
             
Electro and Communications   5.6 %   0.8 %   6.4 %
             
Safety, Security and Protection Services   13.2 %   1.2 %   14.4 %
             

Note: Industrial and Transportation includes a 4.6 percent benefit from acquisitions, primarily
CUNO, which was acquired in August 2005. Safety, Security and Protection Services includes
a 4.0 percent benefit from acquisitions, primarily Security Printing and Systems Limited.

 
 
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Dollars in millions)
(Unaudited)
 

BUSINESS
SEGMENT
INFORMATION
(Millions)

  Three-months ended
Dec. 31
  Twelve-months ended
Dec. 31
                 
    2006   2005   2006   2005
NET SALES                
Industrial and Transportation   $1,683     $1,558     $6,754     $6,144  
Health Care   1,047     929     4,011     3,760  
Display and Graphics   946     901     3,765     3,511  
Consumer and Office   824     765     3,238     3,033  
Electro and Communications   619     585     2,483     2,333  
Safety, Security and Protection Services   655     563     2,621     2,292  
Corporate and Unallocated   8     24     51     94  
Total Company   $5,782     $5,325     $22,923     $21,167  
                 
OPERATING INCOME                
Industrial and Transportation   $301     $298     $1,343     $1,211  
Health Care   999     285     1,845     1,114  
Display and Graphics   225     286     1,062     1,162  
Consumer and Office   141     142     579     561  
Electro and Communications   64     113     438     447  
Safety, Security and Protection Services   118     127     575     537  
Corporate and Unallocated   (38 )   (61 )   (146 )   (178 )
Total Company   $1,810     $1,190     $5,696     $4,854  
                 

Refer to Note (a) for discussion of the sales of 3M’s global branded pharmaceuticals business,
which resulted in a gain on sale of $1.074 billion (reflected in Health Care segment). In addition,
the Health Care segment included $284 million in restructuring costs, primarily employee related
severance and benefit costs. Of the $284 million, $157 million was related to the pharmaceuticals
business (refer to notes (b) and (c)), $112 million of severance and benefit costs related to
restructurings in certain corporate functions (refer to note (d)), and $15 million related to Health
Care severance and other costs (refer to note (e)). Health Care also included $95 million of
expensed in-process research and development costs related to the Brontes acquisition (refer to
note (f)). In total, the combination of the above items positively impacted the fourth quarter 2006
Health Care operating income by $695 million. The Company also incurred costs related to the
sale of the branded pharmaceuticals business in the second and third quarters of 2006 totaling
$22 million, which combined with the preceding items, positively impacted total year 2006 Health
Care operating income by $673 million.

 

In connection with the sale of the branded pharmaceuticals business, the Company also decided to
restructure certain products and businesses to streamline its cost structure following the sale
of the branded pharmaceuticals business (refer to note (e)). Fourth-quarter 2006 included costs
related to these restructuring actions, primarily severance, fixed asset impairments and intangible
impairments. Refer to the preceding Supplemental Consolidated Statement of Income Information
section for a table showing the impacts of these actions by business segment. Corporate and
Unallocated in the second quarter of 2006 included a $40 million charge for a class action settlement
(refer to note g).

 
 
3M Company and Subsidiaries
SFAS 123R STOCK OPTION EXPENSE IMPACT (p)
(Dollars in millions, except per share amounts)
(Unaudited)
             
    Three months ended
    Dec. 31
    2006   2005   Difference
Cost of sales   $9   $4   $5
% to Sales   0.2%   0.1%   0.1%
Selling, general and administrative expenses   $21   $13   $8
% to Sales   0.4%   0.2%   0.2%
Research, development and related expenses   $8   $5   $3
% to Sales   0.1%   0.1%   0.0%
Operating Income   $38   $22   $16
% to Sales   0.7%   0.4%   0.3%
             
 
SFAS 123R STOCK OPTION EXPENSE IMPACT (p)
(Dollars in millions, except per share amounts)
(Unaudited)
             
    Twelve months ended
    Dec. 31
    2006   2005   Difference
Cost of sales   $42   $27   $15
% to Sales   0.2%   0.1%   0.1%
Selling, general and administrative expenses   $119   $96   $23
% to Sales   0.5%   0.4%   0.1%
Research, development and related expenses   $39   $32   $7
% to Sales   0.2%   0.2%   --
             
Operating Income   $200   $155   $45
% to Sales   0.9%   0.7%   0.2%
             
 
3M Company and Subsidiaries
BUSINESS SEGMENT STOCK OPTION EXPENSE (p)
(Dollars in millions)
(Unaudited)
             
    Three-months ended Dec. 31
    2006   % to Sales   2005   % to Sales
Industrial and Transportation   $11   0.6%   $7   0.4%
Health Care   8   0.8%   5   0.5%
Display and Graphics   5   0.6%   2   0.3%
Consumer and Office   5   0.6%   3   0.4%
Electro and Communications   4   0.6%   3   0.4%
Safety, Security and Protection Services   5   0.7%   2   0.4%
Corporate   --   --   --   --
Total Company   $38   0.7%   $22   0.4%
                 
 
BUSINESS SEGMENT STOCK OPTION EXPENSE (p)
(Dollars in millions)
(Unaudited)
 
    Twelve months ended Dec. 31
    2006   % to Sales   2005   % to Sales
Industrial and Transportation   $51   0.8%   $47   0.8%
Health Care   42   1.1%   35   0.9%
Display and Graphics   27   0.7%   19   0.5%
Consumer and Office   24   0.7%   21   0.7%
Electro and Communications   20   0.8%   17   0.7%
Safety, Security and Protection Services   21   0.8%   16   0.7%
Corporate   15   --   --   --
Total Company   $200   0.9%   $155   0.7%
                 
 
3M Company and Subsidiaries
QUARTERLY DILUTED EARNINGS PER SHARE,
INCLUDING STOCK OPTION IMPACT (p)
(Unaudited)
                     

2004 Reported

  Q1   Q2   Q3   Q4   Total
EPS as originally reported   $0.90     $0.97     $0.97     $0.91     $3.75  
SFAS 123R impact   $(0.03 )   $(0.04 )   $(0.06 )   $(0.06 )   $(0.19 )

EPS with SFAS123R impact

  $0.87     $0.93     $0.91     $0.85     $3.56  
                     
                     

2005 Reported

  Q1   Q2   Q3   Q4   Total
EPS as originally reported   $1.03     $1.00     $1.10     $0.99     $4.12  
SFAS 123R impact   $(0.06 )   $(0.04 )   $(0.02 )   $(0.02 )   $(0.14 )
EPS with SFAS123R impact   $0.97     $0.96     $1.08     $0.97     $3.98  
                     
                     

2005 - Excluding

                   

Special Items (q)

  Q1   Q2   Q3   Q4   Total
EPS as originally reported   $1.03     $1.09     $1.10     $1.04     $4.26  
SFAS 123R impact   $(0.06 )   $(0.04 )   $(0.02 )   $(0.02 )   $(0.14 )
EPS with SFAS123R impact   $0.97     $1.06     $1.08     $1.01     $4.12  
                     
                     

2006 - Reported

  Q1   Q2   Q3   Q4   Total
Diluted EPS   $1.17     $1.15     $1.18     $1.57     $5.06  
SFAS 123R impact included in EPS   $(0.02 )   $(0.07 )   $(0.04 )   $(0.04 )   $(0.17 )
                     
                     

2006 - Excluding

                   

Special Items (q)

  Q1   Q2   Q3   Q4   Total
Diluted EPS   $1.17     $1.05     $1.17     $1.10     $4.49  
SFAS 123R impact included in EPS   $(0.02 )   $(0.07 )   $(0.04 )   $(0.04 )   $(0.17 )
                     
                     

2007 - Reported - Estimated (r)

  Q1   Q2   Q3   Q4   Total
Diluted EPS Guidance                   $5.20-$5.45  
Estimated SFAS 123R impact included in EPS guidance   $(0.04 )   $(0.09 )   $(0.04 )   $(0.04 )   $(0.21 )
                     
                     

2007 - Excluding

                   

Special Items - Estimated (q)

  Q1   Q2   Q3   Q4   Total
Diluted EPS Guidance                   $4.60-$4.75  
Estimated SFAS 123R impact included in EPS guidance   $(0.04 )   $(0.09 )   $(0.04 )   $(0.04 )   $(0.21 )
                     

(p) 3M adopted Statement of Financial Accounting Standards No. 123R effective Jan. 1, 2006, using the
modified retrospective method, with prior periods adjusted to give effect to the fair-value-based method
of accounting for stock option awards granted in fiscal years beginning on or after Jan. 1, 1995. The fourth
quarter and year 2006 stock-based compensation expense is higher for the same reasons cited in previous
quarters. First, effective Jan. 1, 2006, accounting rules required acceleration of stock-based compensation
expense recognition when an employee is eligible to retire, instead of over the entire vesting period for these
retirement-eligible employees, resulting in recognition of approximately 25 percent of the expense in the month
of grant (second quarter for 3M’s annual stock option grant). Second, 3M changed its vesting period from one
to three years starting with the May 2005 grant. The third and fourth quarter of 2006 include expense from both
the 2005 and 2006 stock option grants, while the third and fourth quarter of 2005 only include expense from the
2005 stock option grant.

 

(q) In addition to disclosing results that are determined in accordance with U.S. generally accepted accounting
principles (GAAP), the company also discloses non-GAAP results that exclude special items. Special items
represent significant charges or credits that are important to an understanding of the company’s ongoing
operations. The company provides reconciliations of its non-GAAP financial reporting to the most comparable GAAP
reporting. The company believes that discussion of results excluding special items provides a useful analysis of
ongoing operating trends. Earnings per share and other amounts before special items are not measures recognized
under GAAP. The determination of special items may not be comparable to similarly titled measures used by other
companies. Refer to the preceding “Supplemental Consolidated Statement of Income Information” for discussion
of the special items that impacted 2006 and 2005, and the below note (r) for special items that will impact 2007.

 

(r) The total year 2007 estimate of reported EPS includes the gain on sale of the branded pharmaceuticals
business in Europe, which is expected to benefit first quarter and total year 2007 by approximately $0.60 to
$0.70 per diluted share, net of known restructuring costs.

 
 
3M Company and Subsidiaries
NEW ACCOUNTING PRONOUNCEMENTS DISCUSSION
(Unaudited)
 

In September 2006, the Financial Accounting Standards Board issued SFAS No. 158, “Employers’
Accounting for Defined Benefit Pension and Other Postretirement Plans.” This standard requires
employers to recognize the underfunded or overfunded status of a defined benefit postretirement
plan as an asset or liability in its statement of financial position. As a result of the implementation
of SFAS No. 158, the Company recognized an after-tax decrease in accumulated other comprehensive
income (which is part of stockholders’ equity) of approximately $1.2 billion and $500 million for the
U.S. and international pension benefit plans, respectively, and approximately $200 million for the
postretirement welfare benefit plans. This decrease of $1.9 billion in the fourth quarter of 2006 in
accumulated other comprehensive income is primarily due to our historical discretionary contributions
being in excess of book expense. These excess contributions as of our last measurement date of
Dec. 31, 2005 were classified in accordance with SFAS No. 87 as a prepaid asset. This change
impacts the Consolidated Balance Sheet only, with no impact to net income or cash flows.

 

In June 2006, the Financial Accounting Standards Board (FASB) issued Financial Interpretation No. 48,
Accounting for Uncertainty in Income Taxes (FIN 48). FIN 48 prescribes a more-likely-than-not threshold
for financial statement recognition and measurement of a tax position taken or expected to be taken in a
tax return. This interpretation also provides guidance on derecognition of income tax assets and liabilities,
classification of current and deferred income tax assets and liabilities, accounting for interest and penalties
associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.
This interpretation is effective as of Jan. 1, 2007 and the cumulative effects, if any, of applying this
interpretation will be recorded as an adjustment to retained earnings as of Jan. 1, 2007. The Company
does not expect the adoption of FIN 48 to have a material impact on 3M’s consolidated results of
operations or financial condition.

 
3M Company and Subsidiaries
SUPPLEMENTAL CONDENSED CONSOLIDATED BALANCE SHEET INFORMATION
(Dollars in millions)
(Unaudited)
        Impact as of Transaction Date
since Sept. 30, 2006
   

Dec. 31,
2006

 

Pharma
impact

 

Pension

 

Special
items

ASSETS                
Current Assets                
Cash and cash equivalents   $1,447   $1,209     $-     $(95 )
Other current assets   7,499   (45 )   -     44  
Total current assets   8,946   1,164     -     (51 )
Marketable securities - non-current   166   -     -     -  
Investments   314   -     -     -  
Property, plant and equipment - net   5,907   (76 )   -     (47 )
Prepaid pension and postretirement benefits   394   -     (2,496 )   -  
Goodwill, intangible assets and other assets   5,580   (54 )   (24 )   (39 )
Total assets   $21,307   $1,034     $(2,520 )   $(137 )
LIABILITIES AND STOCKHOLDERS' EQUITY                
                 
Total current liabilities   7,323   436     -     101  
                 
Long-term debt   1,047   -     -     -  
Other liabilities   2,965   -     (622 )   -  
Total liabilities   11,335   436     (622 )   101  
Total stockholders' equity - net   9,972   598     (1,898 )   (238 )
Total liabilities and stockholders' equity   $21,307   $1,034     $(2,520 )   $(137 )
 

 

3MInvestor Contacts:Matt Ginter, 651-733-8206orBruce Jermeland, 651-733-1807Media Contact:Jacqueline Berry, 651-733-3611

Other Topics

Contact Media Relations

Contact Media Email
 

These contacts are intended only for the media. If you are not a member of the media, please call 1-888-3M HELPS (1-888-364-3577).
 

We will get back to you within one business day.

Email Alerts

Subscribe to receive automatic updates via email for 3M news & stories.

Subscribe